Compact Herbal Composition for Environmental Sensitivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing compositions for regulating immune and non-immune mediated environmental sensitivities are large in volume, expensive to produce, and difficult to standardize due to the large number of ingredients, making them inefficient and costly.
Innovation Solution
A compact composition comprising 2-95 weight percent Psoralea, 2-95 weight percent Xanthium, and 2-95 weight percent of either Gardenia or Scutellaria, or a mixture of these, which can be formulated into various delivery forms to provide an effective dose for treating environmental sensitivities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If an eleven-ingredient formula is used to treat environmental sensitivities, then beneficial effects against environmental irritants are achieved, but the composition becomes large in volume and expensive to produce
Solution Approach 1:
The patent extracts and identifies the three most critical ingredients (Psoralea, Xanthium, and either Gardenia or Scutellaria) from the original eleven-ingredient formula. This extraction process removes unnecessary ingredients while retaining the core therapeutic components, resulting in a more compact and cost-effective composition that maintains efficacy against environmental sensitivities.
Solution Approach 2:
The simplified three-ingredient composition maintains universal effectiveness against multiple types of environmental irritants (pollen, dust, temperatures, air pollution, foods) that the original eleven-ingredient formula treated. This multi-functionality is achieved with fewer ingredients, reducing volume and production cost while preserving broad-spectrum therapeutic benefits.
2Reliability
If an eleven-ingredient formula is used to treat environmental sensitivities, then beneficial effects against environmental irritants are achieved, but production cost increases
Solution Approach 1:
The patent extracts and identifies the three most critical ingredients (Psoralea, Xanthium, and either Gardenia or Scutellaria) from the original eleven-ingredient formula. This extraction process removes unnecessary ingredients while retaining the core therapeutic components, resulting in a more compact and cost-effective composition that maintains efficacy against environmental sensitivities.
Solution Approach 2:
The patent changes the compositional parameters by reducing the number of ingredients from eleven to three, and specifies weight percentage ranges (2-95% for each ingredient) that optimize both efficacy and manufacturing efficiency. This parameter optimization reduces production complexity and cost while maintaining therapeutic effectiveness.
3Adaptability or versatility
If an eleven-ingredient formula is used to treat environmental sensitivities, then broad coverage of environmental irritants is achieved, but consistency and standardized functionality become difficult to maintain
Solution Approach 1:
The patent changes the compositional parameters by reducing the number of ingredients from eleven to three, and specifies weight percentage ranges (2-95% for each ingredient) that optimize both efficacy and manufacturing efficiency. This parameter optimization reduces production complexity and cost while maintaining therapeutic effectiveness.
Solution Approach 2:
The patent applies local quality by focusing on the specific therapeutic properties of three key ingredients rather than distributing functionality across eleven ingredients. Each ingredient has a defined role and concentration range, enabling precise control over the composition's standardized functionality while maintaining broad adaptability to different environmental irritants.
Data Source
AI summary
The present invention is directed to compositions for improving immune function and sensitivities to the natural and manmade environment that include ingredients from natural sources. It is further directed to methods of administering the compositions and kits containing the compositions. In a composition aspect, the composition is for regulating immune function and non-immune related sensitivities. It consists essentially of: 2 weight percent to 95 weight percent Psoralea; 2 weight percent to 95 weight percent Scutellaria; and 2 weight percent to 95 weight percent Xanthium. The Scutellaria portion may be replaced by Gardenia (in equal measure), or by a mixture of Scutellaria and Gardenia.